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The effect is dependent on the particular spe-
cies; similar experiments with E. coli exhibited 
no such spatially dependent enhancement. The 
effect, termed ‘quorum acting’, differs from the 
well-known phenomenon of quorum sensing7 
in that the latter is defined by alterations in the 
cellular phenotype itself, whereas this new effect 
is characterized by alterations to the external 
environment induced by spatial localization of 
the cells.
Microfluidic devices enable the study of vari-
ous phenomena in the presence of precisely 
controlled flow conditions, and Kastrup et al.3 
used this capability to demonstrate that clus-
ters of B. cereus still initiate coagulation in the 
presence of flowing whole blood. Experiments 
also confirmed that specific coagulation factors 
must be present for the quorum acting process, 
while others are not essential, and therefore, a 
coagulation network in which quorum acting 
bypasses some of the initiation points can be 
mapped. Numerous Bacillus species activate 
coagulation in vitro; one interesting finding 
is that B. anthracis requires a specific metallo-
protease in order to trigger coagulation. Mouse 
models injected with B. anthracis also exhibited 
a strong correlation between the bacterial clus-
tering and coagulation, but differences between 
mouse and human infection and pathophysiol-
ogy complicate the picture considerably.
The ability of microfluidic models to simu-
late coagulation-related phenomena is an excit-
ing advance with many potential applications 
in basic research and in the development of 
new therapeutic approaches. Septic shock and 
related conditions have long been associated 
with coagulation, and yet a complete picture 
of the mechanisms activating and controlling 
this correlation has not emerged. With new 
insights into quorum acting phenomena and 
the ways in which bacteria communicate to 
influence not only their own behavior but also 
that of the local environment, a deeper under-
standing of infection-induced coagulation is 
possible. Many questions remain, however, as 
effects such as coagulation in the presence of 
B. anthracis seen in vitro and in animal models 
may not be consistent with recent human clin-
ical experience8. Future work along the lines of 
Kastrup et al.3 is likely to be very instructive in 
addressing key questions, such as the relation-
ship between bacterial infections and cardio-
vascular disease, the evolution of cooperative 
effects within host responses and within bac-
terial populations, and approaches towards 
reducing the incidence of coagulation related 
to microbial contamination and biofilms in 
vascular access management.
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Cyclization in concert
Marco W Fraaije & Andrea Mattevi
The berberine bridge enzyme catalyzes the crucial step in the biosynthesis of an important class of alkaloids through 
a reaction that cannot be carried out using conventional organic chemistry tools. Characterization of the enzyme 
demonstrates a concerted mechanism that couples two distinct chemical steps—oxidation and proton abstraction—
affecting two separate groups of the substrate.
Berberine bridge enzyme (BBE, Enzyme 
Commission number 1.21.3.3) catalyzes a key 
reaction in the biosynthetic pathways toward 
a major and diverse class of plant alkaloids—
the benzophenanthridines. These molecules 
have been widely studied because of their 
many potential applications that range from 
hypotension treatment to anticancer activ-
ity1. Consistently, there is a growing demand 
to understand and engineer cellular and bio-
catalytic systems that can efficiently synthe-
size these compounds1. BBE shows a highly 
refined selectivity and reactivity, as it specifi-
cally recognizes the S enantiomer of reticu-
line, which is converted into (S)-scoulerine by 
a regioselective cyclization reaction (Fig. 1a). 
This atypical oxidative cyclization generates a 
chemical link (“berberine bridge”) between the 
substrate isoquinoline and benzyl rings, which 
results in the formation of the tetracyclic skel-
eton of berberine-related alkaloids. A crucial 
feature of the reaction is that such a selective 
modification cannot be achieved by synthetic 
organic chemistry. Therefore, BBE represents 
an invaluable biocatalytic tool for synthetic 
biology approaches aiming at the production 
of bioactive alkaloids2. The structural and bio-
chemical analysis of the enzyme reported by 
Winkler et al.3 in this issue of Nature Chemical 
Biology represents an important advance, pro-
viding conclusive evidence in support of an 
unprecedented mechanism of catalysis.
Though BBE activity was already known for 
several decades4, the mechanism by which the 
berberine bridge is formed remained elusive5. 
The combination of mutagenesis of several 
active site residues, kinetic analyses and a crys-
tal structure of the enzyme from Eschscholzia 
californica in complex with (S)-reticuline sup-
ports a mechanism in which a hydride anion 
is transferred from the N-methyl group of the 
substrate isoquinoline ring to the flavin group 
of the FAD cofactor. Furthermore, the authors 
demonstrate that the two-electron oxidation of 
the substrate is coupled to a regioselective pro-
ton abstraction from the substrate benzyl group 
by an essential glutamate residue (Glu417) 
(Fig. 1b). This concerted “proton and hydride” 
abstraction gives rise to a Friedel-Crafts–like 
alkylation, eventually yielding the ring-closed 
(S)-scoulerine. Key to this elegant solution for 
a seemingly complex reaction is the proper 
orientation of the substrate with respect to 
the two catalytic groups; the flavin cofactor, 
the N-methyl group of the substrate isoquino-
line ring, the hydroxyl group of the substrate 
benzyl ring and the carboxylate of Glu417 are 
precisely aligned within the active site to pro-
mote catalysis3. This binding mode is at the 
heart of the catalytic mechanism uncovered 
by this study.
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tion reaction while acting on compounds with 
a different scaffold with respect to that of reti-
culine (Fig. 1c)7,8. As both enzymes show high 
sequence homology to BBE (40% sequence 
identity), including conservation of the FAD-
linking residues and the active site glutamate, 
these synthases are likely to use a similar con-
certed reaction that couples oxidation with 
proton abstraction.
A striking structural feature of BBE and 
the above-mentioned synthases is the mode in 
which the FAD cofactor is bound: it is cova-
lently tethered to the polypeptide chain via two 
residues. Such an 8α-histidyl-6-S-cysteinyl-
FAD cofactor has only been observed in a 
small number of recently reported oxidases9. 
Except for this characteristic mode of cofactor 
The structural and mechanistic insights into 
BBE function are relevant for the analysis of 
related enzymes. In fact, plant genomes appear 
to be rich in BBE homologs. For instance, 
12 homologs have been observed in the 
Arabidopsis thaliana genome6. This indicates 
that enzymes of the BBE family are likely to 
be involved in diverse and yet-unknown pro-
cesses of plant metabolism, thus representing 
a reservoir of catalytic potential that remains to 
be explored. This notion is exemplified by the 
BBE homologs that have already been shown 
to take part in the biosynthesis of another 
class of plant alkaloids—the cannabinoids1. 
∆-Tetrahydrocannabinolic acid synthase and 
cannabidiolic acid synthase from Cannabis 





































































































binding, members of this subclass of bicova-
lent flavoproteins also share another feature: 
they act on relatively complex molecules, often 
secondary metabolites. This may also relate to 
the rationale behind the double covalent FAD 
linkage. To create an active site that accom-
modates a bulky substrate molecule, while 
assuring appropriate positioning of residues 
and the flavin cofactor, a tight anchoring of 
the cofactor may be beneficial. Future studies 
on the recently discovered bicovalent flavopro-
teins will clarify the exact functional role of the 
double covalent anchoring of the cofactor.
Structural and mechanistic knowledge 
enables dedicated enzyme redesign by which 
new synthetic routes can be developed. In fact, 
one of the BBE mutants reported by Winkler 
Figure 1  Biochemistry of BBE and homologous enzymes. (a) BBE catalyzes the conversion of (S)-reticuline to (S)-scoulerine, a cyclization reaction that 
involves the formation of the so-called berberine bridge that links the benzyl and isoquinoline rings of the substrate. Reticuline is synthesized from l-tyrosine, 
whereas the product of the BBE reaction represents the precursor of a wide and diverse group of alkaloids that have various biological activities. (b) Simplified 
scheme of the catalytic mechanism of BBE proposed by Winkler et al.3. (c) Plant genomes exhibit a number of BBE homologs whose biological activities 
remain mostly to be uncovered. Among the BBE homologs, there are enzymes that take part in the biosynthesis of cannabinoids. Remarkably, these synthases 
act on molecules that substantially differ from reticuline, highlighting the biocatalytic potential and diversity of the family of BBE-related enzymes.
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et al.3 already shows formation of a new ring 
closure product, (S)-coreximine. Adapting 
BBE and related proteins toward other sub-
strate types (by directed evolution for example) 
will aid synthetic biology approaches aiming 
at generation of new pharmaceuticals (see for 
example ref. 10). In fact, nature already illus-
trates such flexibility in selectivity, as BBE 
homologs of the cannabinoid metabolism act 
on compounds that are chemically and biologi-
cally unrelated to reticuline and similar alka-
loids (Fig. 1). The results presented by Winkler 
et al.3 and the recent successful attempts of 
metabolic pathway engineering1 indicate that 
the biocatalytic potential of BBE and similar 
enzymes is still largely unexplored and will 
represent a major topic for future research.
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Seeing cellular sialidase transform sugars
Minoru Fukuda & Xingfeng Bao
Cell-surface carbohydrates are synthesized in a step-wise fashion, yielding products with unique capping structures. 
A recent study has shown that carbohydrates at the cell surface can be further remodeled by an endogenous 
glycosidase to alter the carbohydrate structure, thus generating a new function.
Carbohydrates serve important roles in eukary-
otic cells, and in particular they function as 
intercellular regulators when displayed on 
the cell surface as protein or lipid conjugates. 
These often complex sugar structures are typi-
cally synthesized in the endoplasmic reticulum 
and Golgi apparatus by the step-wise addition 
of different carbohydrate residues onto the 
appropriate biological scaffold by glycosyl-
transferases. This occurs in the creation of 
mucin-like O-glycans, which are initiated by 
the addition of N-acetylgalactosamine to serine 
or threonine residues1. Unlike DNA and pro-
tein synthesis, however, carbohydrate synthesis 
does not always proceed in a forward direction; 
instead, individual or several sugar residues can 
be removed, or ‘trimmed’, from a growing chain 
while in the endoplasmic reticulum and Golgi. 
This processing is well known, for example in 
the case of converting mannose-rich N-glycans 
to precursor N-glycans in the Golgi by man-
nosidases, a required step in converting the 
carbohydrates present in yeast to the more 
complex N-glycans in animal and plant cells2. 
The significance of appropriate carbohydrate 
modification is illustrated by neonatal lethality 
in mice with inactivated α-mannosidases3. A 
new study now demonstrates a surprising link 
between these systems in describing a mucin-
like sugar epitope modification of existing gly-
coproteins by a post-Golgi enzymatic activity 
that underlies myeloid cell maturation and 
differentiation4.
Two particularly important sugars found 
on the surface of myeloid cells are the CD15 
antigen (or Gal-β(1-3)-[Fuc-α(1-3)]-GlcNAc; 
also known as Lewis x) and its sialylated analog, 
sialyl-CD15 (or sialic acid–α(2-3)-Gal-β(1-4)-
[Fuc-α(1-3)]-GlcNAc; also known as CD15s or 
sialyl-Lewis x). These closely related structures 
have surprisingly different functions: neutro-
phils—a type of white blood cell in the myel-
oid lineage—use CD15s-selectin interactions 
to initiate cell adhesion with endothelial cells 
as part of the inflammatory response5. Once 
neutrophils have entered subendothelial tis-
sues, the cell surface is altered to display CD15, 
which does not bind selectin, but instead serves 
as a ligand for the lectin DC-SIGN on dendritic 
cells. This pairing is one factor that neutrophils 
use to initiate dendritic cell maturation6; it 
engages both neutrophils and dendritic cells 
in attacking pathogens.
Though the functional significance of the 
display of either CD15s or CD15 is clear, 
the mechanism controlling which sugar is 
displayed was not known. The replacement 
of CD15s could result from vigorous new 
synthesis of CD15, thus diluting CD15s. 
Alternatively, CD15s could be directly digested 
by an endogenous sialidase and converted to 
CD15 through a new mechanism. Gadhoum 
and Sackstein now use inhibitors of specific 
points in carbohydrate synthesis to show that 
CD15 is surprisingly generated by the latter 
mechanism4 (Fig. 1). Even more surprisingly, 
by measuring the sialidase activity of intact 
cells, the authors show that the majority, if not 
all, of the sialidase activity that cleaves CD15s 
is present on the cell surface.
To remove sialic acid from the cell surface, 
four distinct sialidases reported are consid-
ered7. Among them, only Neu-1 and Neu-3 
can hydrolyze sialic acid conjugate. Gadhoum 
and Sackstein showed that Neu-1 is most 
likely responsible for the conversion of CD15s 
to CD15 by demonstrating that the levels of 
its transcripts and protein were increased 
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Figure 1  Biosynthetic pathway of mucin-like 
O-glycans. Once mucin-type O-glycans are 
synthesized in the Golgi by glycosyltransferases 
(GTs), the corresponding mucin-like glycoproteins 
are transported to the plasma membrane. 
Gadhoum and Sackstein showed that CD15s 
(sLex) on mucin-type glycoproteins is further 
subjected to processing by an endogenous 
sialidase on the cell surface, thus forming CD15 
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